Thursday, March 30, 2023 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

WILMINGTON, Del. - Shareholders say directors of Cephalon breached their fiduciary by rejecting a $73 per share, $5.7 billion buyout offer from Valeant Pharmaceuticals.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.